2024-25 Annual report
Financial highlights
Read the 2024-25 audited financial statements
Statement of operations and changes in net assets
Year ended March 31, 2025
| Expenses | 2025 | 2024 |
|---|---|---|
| Decrease risk of people getting cancer in Canada | 3,681,283 | 2,381,154 |
| Diagnose cancer faster, accurately and at an earlier stage | 9,214,088 | 4,943,768 |
| Deliver high-quality care in a sustainable, world-class system | 2,177,000 | 1,415,758 |
| Deliver supports for patients, families and caregivers | 5,364,356 | 1,902,124 |
| Culturally appropriate care closer to home | 5,464,542 | 2,801,646 |
| First Nations-, Inuit-, or Métis-governed research and data systems | 2,231,591 | 783,745 |
| Transforming research into improved care | 8,499,632 | 7,727,850 |
| Maximizing the impact of health system data to drive change and improving information flow among providers and patients | 7,398,720 | 4,526,999 |
| Public engagement and outreach and cancer strategy program support | 7,037,354 | 6,000,931 |
51,068,566 | 32,483,975 | |
| Operating expenses (Note 4)* | 10,680,861 | 11,040,412 |
61,749,427 | 43,524,387 |
| Revenue | 2025 | 2024 |
|---|---|---|
| Government of Canada (Note 6)* | 61,637,178 | 42,537,277 |
| Other funding | 112,249 | 987,110 |
61,749,427 | |
| Excess of revenue over expenses for the year, and net assets at the end of the year | – | – |
|---|
Statement of financial position
As at March 31, 2025
Assets
| Current | 2025 | 2024 |
|---|---|---|
| Cash | 3,046,075 | 7,184,587 |
| Short-term investments | 2,997,188 | 10,584,961 |
| Accounts receivable | 574,285 | 485,822 |
| Projects in process – advances (Note 3)* | 1,040,126 | 995,186 |
| Prepaid expenses | 2,060,523 | 1,414,791 |
9,718,197 | | |
| Capital assets (Note 4)* | 1,535,224 | 1,943,325 |
| | |
11,253,421 | |
Liabilities and net assets
| Current | 2025 | 2024 |
|---|---|---|
| Accounts payable and accrued liabilities | 5,625,993 | 3,661,621 |
| Government remittances payable (Note 5)* | 52,077 | 44,463 |
| Deferred contributions – Expenses of future periods (Note 6 (a))* | 3,764,102 | 16,644,680 |
9,442,172 | | |
| Deferred contributions – Capital assets (Note 6 (b))* | 1,275,720 | 1,601,873 |
| Lease inducements (Note 7)* | 535,529 | 656,035 |
1,811,249 | | |
11,253,421 | | |
| Net assets | – | – |
11,253,421 | |
*Refer to the audited financial statements for full details on the note.
Statement of cash flows
Year ended March 31, 2025
Increase (decrease) in cash
| Operating activities | 2025 | 2024 |
|---|---|---|
| Government of Canada contributions received (Note 6)* | 47,500,000 | 47,500,000 |
| Other contributions received | 236,868 | 898,549 |
| Interest received on short-term investments | 930,447 | 806,061 |
| Interest paid to Government of Canada | – | (64,151) |
| Cash paid for programs and operating expenses | (60,613,830) | (46,624,371) |
11,946,515 | |
| Investing activities | 2025 | 2024 |
|---|---|---|
| Purchase of short-term investment | – | (6,000,000) |
| Redemption of short-term investment | 8,000,000 | 4,000,000 |
8,000,000 | (2,000,000) |
| Financing activities | 2025 | 2024 |
|---|---|---|
| Purchase of capital assets | (191,997) | (680,499) |
(191,997) | |
| Increase (decrease) in cash | (4,138,512) | (164,411) |
|---|---|---|
| Cash, beginning of year | 7,184,587 | 7,348,998 |
| Cash, end of year | 3,046,075 | 7,184,587 |